CME
Updates in the Management of Early Alzheimer’s Disease
Host: Richard S. Isaacson, MD
Guest: Marc E. Agronin, MD
Despite decades of research, there are only a handful of FDA-approved drugs available for patients with Alzheimer’s disease (AD). Fortunately, several promising agents for the treatment of AD